Lois Hole Hospital for Women, Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9, Canada
NCT Number: NCT03296462
This RCT is a feasibility study to evaluate the Lois Hole Hospital for Women's Urogynecology Clinic's ability to recruit and randomize SUI patients to the proposed RCT, and to test the study procedures and follow-up schedule for participants.
The study interventions used in the feasibility study will be training of (1) Hip Extension Rotation (HER) exercises alone, (2) HER exercises in combination with Pelvic Floor Muscle (PFM) exercises, or (3) PFM exercises alone (control/usual care) in the treatment of SUI.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Edmonton, Alberta, T5H 3V9, Canada
Background: Hip External Rotation (HER) exercises are being adopted into physiotherapy practice for the treatment of stress urinary incontinence (SUI) despite little evidence compared to the proven effective standard of care treatment, pelvic floor muscle (PFM) exercises. A randomised clinical trial (RCT) is needed to determine whether HER exercise alone or in combination with PFM is more or less effective than PFM exercises alone.
Objective: Before designing an RCT, a feasibility study is needed to evaluate the Lois Hole Hospital for Women's Urogynecology Clinic's ability to recruit and randomize SUI patients to the proposed RCT, and to test the study procedures and follow-up schedule for participants.
Interventions: The interventions used in the feasibility study will be training of (1) HER exercises alone, (2) HER exercises in combination with PFM exercises, or (3) PFM exercises alone (control/usual care) in the treatment of SUI.
Study design: RCT in which participants are randomly allocated 1:1:1 to each intervention.
Outcome Measures: Feasibility outcomes will pertain to recruitment, adherence to training, appropriateness of outcome measures and completion rates. The design of the proposed RCT will be based on these feasibility outcomes.
Outcome measures for the proposed RCT will include pelvic floor muscle strength, external hip rotator muscle strength, diary-reported urinary incontinence, incontinence related quality of life, and (to test patient mobility) six minute walk test and timed up and go test.
Sample size: The proposed sample size is 30 participants. Duration of study: After recruitment, each woman will undergo 12 weeks of training, with the first outcome measure at the end of that period, and a further follow up at 24 weeks from recruitment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standardised HER exercise training by physiotherapist (plus video recording of exercises)
Standardised PFM exercise training by physiotherapist (plus video recording of exercises)
Time frame: 12 months
Is recruitment feasible? "Feasibility" is defined as achieving recruitment target of 30 recruits within 12 months
Time frame: 12 months
Is follow-up complete for 60% of recruits?
Time frame: 12 & 24 weeks
Strength will be measured using Peritron perineometer
Time frame: 12 & 24 weeks
Strength will be measured using Microfit ET3
Time frame: 12 & 24 weeks
3-day bladder diary to record amount and reason for leakage
Time frame: 12 & 24 weeks
UDI-6 questionnaire (measure of distress caused by incontinence, 0 minimum to 100 maximum)
Time frame: 12 & 24 weeks
IIQ-7 questionnaire (measure of impact of incontinence, 0 minimum to 100 maximum)
Time frame: 12 & 24 weeks
Six minute walk test - distance walked (metres)
Time frame: 12 & 24 weeks
"timed up and go" test - time in sconds
University of Alberta
Other
Physiotherapy for Stress Urinary Incontinence: Feasibility Study for a Randomized Controlled Trial of Hip External Rotation Exercise Training Versus Pelvic Floor Muscle Exercise Training
Acronym: HER-Physio
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT03325543
Behavior, Female Urogenital Diseases
São Paulo, Brazil
View Trial DetailsNCT04171531
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT03672461
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Palo Alto, California, United States
View Trial Details